GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hypera HYPE3.SA · BRL

Health Care · B3 · 🇧🇷 Brazil

Compare

22.33

+0.59%

Close of 17 Nov 2026, in BRL

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Hypera — daily BMFBOVESPA:HYPE3

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Hypera on TradingView ↗
Market value
BRL 14.24bn
Last close × shares
Volume
1.4m
Shares, 17 Nov 2026
Price to earnings
11.5
Dividend yield
4.92%

About Hypera

Its shares trade on B3 under the ticker HYPE3.SA. It has been listed since 16 April 2008. In the fiscal year to 31 December 2025, it reported revenue of BRL 7.70bn and net income of BRL 1.20bn. At that date it held total assets of BRL 25.16bn and shareholders' equity of BRL 12.52bn.

Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2008-04-16. The Company’s major business units include Branded Prescription, Consumer Health and Branded Generics. Branded Prescription is present in the main therapeutic classes in Brazil and it operates in the Primary Care segment under the umbrella brand Mantecorp Farmasa. The Branded Prescription unit also acts as Mantecorp Skincare in dermocosmetics, with products recommended by dermatologists. Consumer Health offers non-prescription drugs, with brands such as Apracur, Benegrip, Coristina d, Engov, Epocler and Estomazil, among others. The Consumer Health unit also operates in nutritionals and vitamin supplements, with brands such as Tamarine, Vitasay, Biotonico Fontoura and Zero-Cal. Branded Generics operates under the Neo Quimica brand.

Figures and description from our data supplier, not checked against the company's own report.

More about Hypera →

Latest on Hypera

Our reporting

Next results

19 Feb 2027

Due on 19 Feb 2027. Analysts expect earnings of 0.73 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Hypera's ticker?

Hypera trades as HYPE3.SA on B3, under ISIN BRHYPEACNOR0.

What was Hypera's last closing price?

22.33 on 17 Nov 2026. The figure is in BRL and is never converted.

When does Hypera next report results?

Results are expected on 19 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.